Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet

Clinical trial NCT01376193 · COMPLETED

Trial details

NCT number: NCT01376193
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Migraine Disorders

Start date: 2009-04-01
Primary completion: 2011-10-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.